Nine of the leaders on this year's list are newcomers: the FDA's Califf, Partners' Torchiana, Dr. Roy Beveridge, CMO at Humana, at No. 16; Humayun Chaudhry, CEO of the Federation of State Medical Boards, No. 28; Dr. Penny Wheeler, CEO at Allina Health, No. 31; Dr. Craig Samitt, chief clinical officer at Anthem, No. 38; Dr. Kenneth Davis, CEO of New York City's Mount Sinai Health System, No. 39; Dr. Francis Crosson, chairman of the Medicare Payment Advisory Commission, No. 41; and Dr. Craig Thompson, CEO of Memorial Sloan Kettering Cancer Center, No. 45.
Thompson points to the quickening pace of breakthroughs in cancer care, thanks to precision medicine, immunotherapy and the development of less-toxic drugs. That's progress he wants to continue to influence. “We're really at a pivotal time when we can deliver on all the basic research and translational research from the past 25 years” leading to targeted treatments for individual tumors. “This isn't science fiction. We're doing it every day.”